| Vivos Therapeutics, Inc. (VVOS) |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | | | | | | | | | | | 2021-Mar-31 | 2020-Dec-31 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | | | | | | | | | | | Q1-FY2021 | Q4-FY2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | 2.18$ | 3.10$ | 3.16$ | 2.93$ | 4.27$ | 2.62$ | 2.24$ | 4.84$ | 11.94$ | 0.19$ | 0.50$ | 0.35$ | 0.40$ | 0.70$ | 1.27$ | 2.70$ | 2.26$ | 4.09$ | 4.93$ | 6.71$ | 5.88$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 19,594,071$ | 23,264,902$ | 18,610,883$ | 17,256,294$ | 20,622,555$ | 8,911,899$ | 7,212,948$ | 13,219,347$ | | | | | | | | 61,592,721$ | 51,555,389$ | 93,301,567$ | 112,463,747$ | 122,203,318$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | (15.78%) | 25.01% | 7.85% | (16.32%) | 131.41% | 23.55% | (45.44%) | | | | | | | | | 19.47% | (44.74%) | (17.04%) | (7.97%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | (4.99%) | 161.05% | 158.02% | 30.54% | | | | | | | | | | | | (49.60%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 8,988,106 | 8,266,877 | 7,324,807 | 5,889,520 | 5,889,520 | 4,765,300 | 3,401,488 | 2,731,270 | 1,833,877 | 1,197,258 | 1,197,258 | 1,197,258 | 920,592 | | | | 920,592 | | 22,812,119 | 18,212,119 | 18,209,452 | | | 12,575,307 | 12,444,165 | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | 8.72% | 12.86% | 24.37% | .00% | 23.59% | 40.10% | 24.54% | 48.93% | 53.17% | .00% | .00% | 30.05% | | | | | | | 25.26% | .02% | | | | 1.05% | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 52.61% | 73.48% | 115.34% | 115.63% | 221.15% | 298.02% | 184.11% | 128.13% | 99.21% | | | | .00% | | | | (94.94%) | | | 44.82% | 46.33% | | | | | | | | | | | | | | | | | | | | | | | | | | | | |